Institute of Digestive Diseases, Longhua Hospital, China-Canada Center of Research for Digestive Diseases (ccCRDD), Shanghai University of Traditional Chinese Medicine, Shanghai 200032, P. R. China.
Shanghai Frontiers Science Center of Disease and Syndrome Biology of Inflammatory Cancer Transformation, Shanghai 200032, P. R. China.
Am J Chin Med. 2024;52(4):1155-1172. doi: 10.1142/S0192415X24500460. Epub 2024 May 22.
Colorectal cancer is the third leading cause of cancer-related death worldwide. Hence, there is a need to identify new therapeutic agents to improve the current repertoire of therapeutic drugs. Wogonin, a flavonoid from the herbal medicine , has unique antitumor activity. Our study aimed to further explore the inhibitory effects of wogonin on colorectal cancer and its specific mechanism. The results showed that wogonin significantly inhibited the proliferation of colorectal cancer cells as well as their ability to invade and metastasize. We detected phosphorylation of tumor-associated signaling pathways using a phosphorylated protein microarray and found that wogonin intervention significantly inhibited the phosphorylation level of the AKT protein in colorectal cancer cells. Through and experiments, it was confirmed that wogonin exerted its antitumor effects against colorectal cancer by inhibiting phosphorylation in the AKT pathway. Our discovery of wogonin as an inhibitor of AKT phosphorylation provides new opportunities for the pharmacological treatment of colorectal cancer.
结直肠癌是全球癌症相关死亡的第三大主要原因。因此,有必要寻找新的治疗药物来改善当前的治疗药物组合。来自草药的黄酮类化合物高黄芩素具有独特的抗肿瘤活性。本研究旨在进一步探索高黄芩素对结直肠癌的抑制作用及其具体机制。结果表明,高黄芩素能显著抑制结直肠癌细胞的增殖以及侵袭和转移能力。我们使用磷酸化蛋白微阵列检测了肿瘤相关信号通路的磷酸化情况,发现高黄芩素干预能显著抑制结直肠癌细胞中 AKT 蛋白的磷酸化水平。通过 和 实验,证实高黄芩素通过抑制 AKT 通路中的磷酸化发挥其对结直肠癌的抗肿瘤作用。我们发现高黄芩素是 AKT 磷酸化的抑制剂,为结直肠癌的药物治疗提供了新的机会。